RWD92 Evaluation of Second and Third Generation Tyrosine Kinase Inhibitor As First-Line Therapy for Non–Small-Cell Lung Cancer Patients: A Multi-Institutional Study in Taiwan

Saved in:

Bibliographic Details
Published in	Value in health Vol. 26; no. 12; p. S521
Main Authors	Cheng, Y.W., Chang, K.C., Chen, H.Y., Fang, Y.F.
Format	Journal Article
Language	English
Published	01.12.2023
Online Access	Get full text

Loading…

More Information
ISSN:	1098-3015
DOI:	10.1016/j.jval.2023.09.2809